Phillip Herrera v. HHS - Tdap, nodular fasciitis (2017)
Case summary [AI summaries can sometimes make mistakes]
Phillip Herrera filed a petition for compensation under the National Vaccine Injury Compensation Program on October 13, 2016, alleging that he developed nodular fasciitis after receiving a Tetanus, Diphtheria, acellular Pertussis (Tdap) vaccine on April 23, 2013. Mr.
Herrera alleged he received the vaccine in the United States, suffered the effects of his injury for more than six months, and had not filed a civil suit or received other compensation for his alleged vaccine-caused injury. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr.
Herrera's nodular fasciitis or any other injury or current condition. Despite the respondent's denial, the parties filed a joint stipulation on October 13, 2016, agreeing that compensation should be awarded.
Chief Special Master Nora Beth Dorsey found the stipulation reasonable and adopted it as the decision of the Court. The parties stipulated that Mr.
Herrera would receive a lump sum of $90,000.00, payable to petitioner, representing compensation for all items of damages available under the Vaccine Act. The public decision does not detail the specific theory of causation, time to onset, symptoms, medical tests, treatments, or expert witnesses.
The decision was based on the joint stipulation of the parties.
Theory of causation
Petitioner Phillip Herrera alleged that he developed nodular fasciitis after receiving a Tdap vaccine on April 23, 2013. The respondent denied causation. The parties filed a joint stipulation agreeing to an award. Petitioner was awarded $90,000.00 as a lump sum. The public decision does not specify a theory of causation, expert testimony, or the mechanism of injury. The decision was based on a joint stipulation, not a finding of causation after litigation. The case was handled by Jerome A. Konkel for the petitioner and Lara A. Englund for the respondent, with Chief Special Master Nora Beth Dorsey issuing the decision on January 11, 2017.
Source PDFs
USCOURTS-cofc-1_16-vv-00321